English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Charles River Terminates Acquisition Plans of WuXi Pharma Tech

Jul. 28, 2010

Charles River Laboratories International, Inc. (NYSE: CRL), a leading global CRO, announced on July 29 that it has agreed with WuXi PharmaTech (Cayman) Inc. (NYSE: WX) to terminate their previously announced acquisition agreement.